Literature DB >> 20461444

In reference to Usery JB et al. (J Neuro-oncol. 2010 Feb 10).

M Maschio, L Dinapoli, B Jandolo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20461444     DOI： 10.1007/s11060-010-0203-z

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  10 in total

1.  Levetiracetam: preliminary experience in patients with primary brain tumours.

Authors:  G L Wagner; E B Wilms; C A Van Donselaar; Ch J Vecht
Journal:  Seizure       Date:  2003-12       Impact factor: 3.184

Review 2.  Drug interactions between chemotherapeutic regimens and antiepileptics.

Authors:  Kevin Yi-Lwern Yap; Wai Keung Chui; Alexandre Chan
Journal:  Clin Ther       Date:  2008-08       Impact factor: 3.393

3.  Levetiracetam therapy in patients with brain tumour and epilepsy.

Authors:  Marta Maschio; Fiorenzo Albani; Agostino Baruzzi; Alessia Zarabla; Loredana Dinapoli; Andrea Pace; Alfredo Pompili; Carmine Maria Carapella; Emanuele Occhipinti; Bruno Jandolo
Journal:  J Neurooncol       Date:  2006-05-10       Impact factor: 4.130

Review 4.  Three new drugs for epilepsy: levetiracetam, oxcarbazepine, and zonisamide.

Authors:  Ilo E Leppik
Journal:  J Child Neurol       Date:  2002-01       Impact factor: 1.987

Review 5.  A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures.

Authors:  Justin B Usery; L Madison Michael; Allen K Sills; Christopher K Finch
Journal:  J Neurooncol       Date:  2010-02-10       Impact factor: 4.130

Review 6.  Optimal seizure management in brain tumor patients.

Authors:  Melanie S M van Breemen; Charles J Vecht
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

Review 7.  Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management.

Authors:  Melanie S M van Breemen; Erik B Wilms; Charles J Vecht
Journal:  Lancet Neurol       Date:  2007-05       Impact factor: 44.182

Review 8.  Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs.

Authors:  Philip N Patsalos; Emilio Perucca
Journal:  Lancet Neurol       Date:  2003-08       Impact factor: 44.182

Review 9.  Treating seizures in patients with brain tumors: Drug interactions between antiepileptic and chemotherapeutic agents.

Authors:  Charles J Vecht; G Louis Wagner; Erik B Wilms
Journal:  Semin Oncol       Date:  2003-12       Impact factor: 4.929

Review 10.  Clinical pharmacokinetics of levetiracetam.

Authors:  Philip N Patsalos
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.